We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

48.91 USD
+0.16
0.33%
At close Updated Oct 30, 12:11 PM EDT
1 day
0.33%
5 days
1.9%
1 month
6.63%
3 months
-2.08%
6 months
-13.16%
Year to date
-20.11%
1 year
-18.85%
5 years
-19.3%
10 years
8.02%
 

About: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Employees: 890

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 42.9%
Neutral 57.1%
Negative 0%
Neutral
Seeking Alpha
2 days ago
Riverwater Small Cap Strategy Q3 2026 Portfolio Update
During the third quarter of 2026, the Small Cap strategy slightly underperformed its benchmark, the Russell 2000 Index, in a period in which small cap stocks broadly declined. Top contributors include AtriCure and Red Violet; top detractors include Kodiak Gas Services and PDF Solutions. We initiated a position in IRadimed at the start of the quarter, replacing Talkspace after it was acquired.
Riverwater Small Cap Strategy Q3 2026 Portfolio Update
Neutral
Zacks Investment Research
15 days ago
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
PBH's brand-building, acquisitions and e-commerce growth support fiscal 2027 revenue gains, but competition and currency risks remain key challenges.
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
Neutral
GlobeNewsWire
16 days ago
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of the market.
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
Positive
Zacks Investment Research
29 days ago
Best Value Stocks to Buy for October 1st
BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.
Best Value Stocks to Buy for October 1st
Positive
Zacks Investment Research
29 days ago
PBH vs. NEOG: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?
PBH vs. NEOG: Which Stock Is the Better Value Option?
Neutral
PRNewsWire
1 month ago
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
While 63% say women are more comfortable discussing intimate wellness than five years ago, new research reveals a gap between cultural progress and personal comfort TARRYTOWN, N.Y., Sept. 30, 2026 /PRNewswire/ -- Women may be talking more openly about intimate health and wellness, but that does not necessarily mean the discomfort has disappeared.
More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds
Positive
Zacks Investment Research
1 month ago
PBH or NEOG: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
PBH or NEOG: Which Is the Better Value Stock Right Now?
Neutral
Seeking Alpha
1 month ago
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Neutral
GlobeNewsWire
1 month ago
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m.
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference
Positive
Zacks Investment Research
1 month ago
Is This the Right Time to Add PBH Stock to Your Portfolio?
Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.
Is This the Right Time to Add PBH Stock to Your Portfolio?
Price charts implemented using Lightweight Charts™